Eugene Stolow1, Chris Moreau2, Hari Sayana2, Sandeep Patel3. 1. Department of Internal Medicine, Long School of Medicine, UT Health San Antonio, San Antonio, TX, 78229-3900, USA. 2. Department of Medicine, Division of Gastroenterology & Nutrition, Long School of Medicine, UT Health San Antonio, San Antonio, TX, 78229-3900, USA. 3. Department of Medicine, Division of Gastroenterology & Nutrition, Long School of Medicine, UT Health San Antonio, San Antonio, TX, 78229-3900, USA. patels7@uthscsa.edu.
Abstract
PURPOSE OF REVIEW: Upper gastrointestinal (GI) bleeding is a significant cause of morbidity and mortality in the geriatric (age > 65 years) population and presents a unique management challenge in the context of multiple medical comorbidities, polypharmacy, and increased risk of adverse outcomes and is confounded by an increased prevalence of obscure GI bleeds. A review of relevant guidelines, literature, and personal observations will enhance management strategies in the elderly. RECENT FINDINGS: Non-variceal bleeding represents a significant proportion of upper GI bleeding (UGIB) in geriatric patients. Peptic ulcer disease (PUD) remains the most common cause in geriatric patients hospitalized for UGIB, but its incidence is decreasing. Esophagogastroduodenoscopy (EGD) is the gold standard for treating UGIB in geriatrics with a therapeutic yield of approximately 75%. Scoring systems such as Glasgow-Blatchford (GBS) and AIMS-65 may be useful for risk stratification but are not validated in trials. Obscure bleeds account for up to 30% of hospitalizations and must be considered during triage and management. Video capsule endoscopy (VCE) technology is efficacious for detecting obscure jejunal bleeding after failed EGD and may enhance the yield of balloon-assisted enteroscopy (BAE). The most significant factor for the increased morbidity and mortality in the geriatric population is the presence of multiple medical comorbidities and polypharmacy. An EGD should be done within 24 h of hospital presentation. If non-diagnostic, VCE may be a viable option for diagnosing an obscure small-bowel bleed, representing up to 30% of GI bleeds in this population.
PURPOSE OF REVIEW: Upper gastrointestinal (GI) bleeding is a significant cause of morbidity and mortality in the geriatric (age > 65 years) population and presents a unique management challenge in the context of multiple medical comorbidities, polypharmacy, and increased risk of adverse outcomes and is confounded by an increased prevalence of obscure GI bleeds. A review of relevant guidelines, literature, and personal observations will enhance management strategies in the elderly. RECENT FINDINGS: Non-variceal bleeding represents a significant proportion of upper GI bleeding (UGIB) in geriatric patients. Peptic ulcer disease (PUD) remains the most common cause in geriatric patients hospitalized for UGIB, but its incidence is decreasing. Esophagogastroduodenoscopy (EGD) is the gold standard for treating UGIB in geriatrics with a therapeutic yield of approximately 75%. Scoring systems such as Glasgow-Blatchford (GBS) and AIMS-65 may be useful for risk stratification but are not validated in trials. Obscure bleeds account for up to 30% of hospitalizations and must be considered during triage and management. Video capsule endoscopy (VCE) technology is efficacious for detecting obscure jejunal bleeding after failed EGD and may enhance the yield of balloon-assisted enteroscopy (BAE). The most significant factor for the increased morbidity and mortality in the geriatric population is the presence of multiple medical comorbidities and polypharmacy. An EGD should be done within 24 h of hospital presentation. If non-diagnostic, VCE may be a viable option for diagnosing an obscure small-bowel bleed, representing up to 30% of GI bleeds in this population.
Authors: Ruben D Acosta; Neena S Abraham; Vinay Chandrasekhara; Krishnavel V Chathadi; Dayna S Early; Mohamad A Eloubeidi; John A Evans; Ashley L Faulx; Deborah A Fisher; Lisa Fonkalsrud; Joo Ha Hwang; Mouen A Khashab; Jenifer R Lightdale; V Raman Muthusamy; Shabana F Pasha; John R Saltzman; Aasma Shaukat; Amandeep K Shergill; Amy Wang; Brooks D Cash; John M DeWitt Journal: Gastrointest Endosc Date: 2015-11-24 Impact factor: 9.427
Authors: Deepak L Bhatt; James Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley Journal: Circulation Date: 2008-10-03 Impact factor: 29.690
Authors: Ian M Gralnek; Jean-Marc Dumonceau; Ernst J Kuipers; Angel Lanas; David S Sanders; Matthew Kurien; Gianluca Rotondano; Tomas Hucl; Mario Dinis-Ribeiro; Riccardo Marmo; Istvan Racz; Alberto Arezzo; Ralf-Thorsten Hoffmann; Gilles Lesur; Roberto de Franchis; Lars Aabakken; Andrew Veitch; Franco Radaelli; Paulo Salgueiro; Ricardo Cardoso; Luís Maia; Angelo Zullo; Livio Cipolletta; Cesare Hassan Journal: Endoscopy Date: 2015-09-29 Impact factor: 10.093
Authors: Jóhann P Hreinsson; Evangelos Kalaitzakis; Sveinn Gudmundsson; Einar S Björnsson Journal: Scand J Gastroenterol Date: 2013-01-29 Impact factor: 2.423
Authors: Rubayat Rahman; Douglas L Nguyen; Umair Sohail; Ashraf A Almashhrawi; Imran Ashraf; Srinivas R Puli; Matthew L Bechtold Journal: Ann Gastroenterol Date: 2016-05-20